What is the recommended treatment for acute bacterial tonsillitis?

Treatment for Bacterial Tonsillitis

Penicillin V (oral) or amoxicillin for 10 days is the first-line treatment for acute bacterial tonsillitis caused by Group A Streptococcus (GAS), with penicillin remaining the gold standard due to its proven efficacy, narrow spectrum, cost-effectiveness, and absence of documented resistance. 1

First-Line Antibiotic Therapy

For Patients WITHOUT Penicillin Allergy:

Penicillin V (oral) - Strong recommendation, high-quality evidence 1:

• Children: 250 mg twice or three times daily for 10 days
• Adolescents/Adults: 250 mg four times daily OR 500 mg twice daily for 10 days

Amoxicillin (oral) - Strong recommendation, high-quality evidence 1:

• 50 mg/kg once daily (max 1000 mg) for 10 days
• Alternative: 25 mg/kg twice daily (max 500 mg/dose) for 10 days

Benzathine Penicillin G (intramuscular) - Strong recommendation, high-quality evidence 1:

• <27 kg: 600,000 units as single dose
• ≥27 kg: 1,200,000 units as single dose
• Particularly useful for compliance concerns

For Patients WITH Penicillin Allergy:

First-generation cephalosporins (avoid in immediate-type hypersensitivity) - Strong recommendation, high-quality evidence 1:

• Cephalexin: 20 mg/kg/dose twice daily (max 500 mg/dose) for 10 days
• Cefadroxil: 30 mg/kg once daily (max 1 g) for 10 days

Clindamycin - Strong recommendation, moderate-quality evidence 1:

• 7 mg/kg/dose three times daily (max 300 mg/dose) for 10 days

Macrolides (note: resistance varies geographically) - Strong recommendation, moderate-quality evidence 1:

• Azithromycin: 12 mg/kg once daily (max 500 mg) for 5 days
• Clarithromycin: 7.5 mg/kg/dose twice daily (max 250 mg/dose) for 10 days

Critical Treatment Rationale

The 10-day treatment duration is essential for several reasons 2, 1:

1. Prevention of acute rheumatic fever - the primary goal of antibiotic therapy
2. Prevention of suppurative complications (peritonsillar abscess, cervical lymphadenitis, mastoiditis)
3. Reduction of transmission to close contacts
4. Symptom improvement and decreased contagiousness

Important caveat: While shorter courses (3-5 days) of late-generation antibiotics show comparable symptom reduction and primary healing, only the 10-day course has proven effective in preventing rheumatic fever and glomerulonephritis 3. Given that rheumatic heart disease, though rare (0.5 per 100,000 school-age children), carries significant morbidity and mortality, the 10-day course remains standard.

Symptomatic Management

Combine antibiotics with:

• NSAIDs (e.g., ibuprofen) for pain and inflammation
• Acetaminophen for additional analgesia
• Corticosteroids (e.g., dexamethasone) may provide symptom relief but are not routinely recommended due to potential adverse effects and the self-limited nature of GAS pharyngitis 1

Common Pitfalls to Avoid

1. Do NOT prescribe antibiotics for viral tonsillitis (70-95% of cases) 4, 5. Use clinical scoring systems (Centor, McIsaac, FeverPAIN) combined with rapid antigen testing when probability is intermediate.

2. Do NOT treat chronic GAS carriers - they are at very low risk for complications and unlikely to spread infection 1. Carriers have positive throat cultures but no active immunologic response.

3. Do NOT use macrolides as first-line therapy - resistance is well-documented and varies geographically 1.

4. Do NOT perform routine post-treatment testing unless symptoms recur 1.

5. Avoid fluoroquinolones - while a 2024 study showed levofloxacin had comparable efficacy to beta-lactams 6, fluoroquinolones are not guideline-recommended for this indication and should be reserved for more serious infections.

Special Considerations for Recurrent Tonsillitis

Tonsillectomy is indicated when a patient has 7, 5:

• ≥7 adequately treated episodes in the preceding year, OR
• ≥5 episodes per year for 2 consecutive years, OR
• ≥3 episodes per year for 3 consecutive years

Do NOT perform tonsillectomy solely to reduce frequency of GAS pharyngitis outside these criteria (strong recommendation, high-quality evidence) 1.

For chronic carriers requiring eradication (rare indications), consider clindamycin 20-30 mg/kg/day in 3 doses for 10 days or penicillin plus rifampin combination 1.